SlideShare a Scribd company logo
CARDIOPULMONARY BYPASS
DR. ARUN SAGAR JR II
MODERATOR: DR RITURAJ
CARDIOPULMONARY CIR
CARDIOPULMONARY BYPASS
• IT IS TO PROVIDE A NON BEATING BLOODLESS
HEART WITH FLOW TEMPORARILY DIVERTED
TO AN EXTRA-CORPOREAL CIRCUIT THAT
FUNCTIONALLY REPLACES HEART AND LUNGS
SURGICAL PROCEDURES REQUIRING
CPB
• CORONARY ARTERY BYPASS SURGERY
• CARDIAC VALVE REPAIR AND/OR REPLACEMENT ( MITRAL
VALVE, TRICUSPID VALVE ETC.)
• REPAIR OF LARGE SEPTAL DEFECTS ( ASD,VSD ETC.)
• REPAIR AND/OR PALLIATION OF CONGENITAL HEART DEFECTS
( TOF , TOGV ETC.)
• TRANSPLANTATION ( HEART TRANSPLANT, LUNGS
TRANSPLANT ETC. )
• REPAIR OF SOME LARGE ANEURYSMS LIKE AORTIC ANEURYSM
• PULMONARY THROMBOENDARTERECTOMY AND
THROMBECTOMY
PREANAESTHETIC WORKUP
• DO THE PAC OF PATIENT WITH HISTORY AND
PHYSICAL EXAMINATION,METS ETC.
• CBC,COAGULATION PROFILE,RENAL AND LIVER
FUNCTION TESTS,
• CHEST X RAY, RESTING ECG ,2D ECHO, STRESS
ECHO
• MYOCARDIAL PERFUSION SCANS
• ANGIOGRAPHY
• CONTRAST VENTRICULOGRAPHY
PATIENT PREPARATION
• PUT A 18G OR PREFERABLY 16G CANNULA
• AN INTERNAL JUGLAR CENTRAL LINE
• A RADIAL AND FEMORAL ARTERIAL LINE( FOR ABG
AND IBP )
• PATIENTS BLOOD TAKEN FOR ACT ( ACTIVATED
CLOTTING TEST) IT IS TIME FROM ADDING BLOOD TO
MACHINE UP TO TIME WHEN FIRST CLOT APPEARS. AN ACT
LONGER THAN 400-480 SECS IS CONSIDERED SAFE.
• HEPARINIZATION FOR ANTICOAGULATION
DURING SURGERY IS BASED ON ACT.
PREMEDICATION AND INDUCTION
• NARCOTICS OR ANXIOLYTICS OR BOTH FOR
PAIN AND ANXIETY AS PREMEDICATION
( PATIENTS WITH EF <40% AND PATIENTS WITH LOW CARDIAC
OUTPUT ---SHOULD BE GIVEN PREOP MEDICATIONS SLOWLY
AND CAREFULLY TO AVOID MYOCARDIAL DEPRESSION AND
HYPOTENSION )
• GOAL OF INDUCTION IS TO AVOID
HYPOTENSION AND ATTENUATE
HEMODYNAMIC RESPONSE TO
LARYNGOSCOPY AND INTUBATION
• SMALL INCREMENTAL DOSES OF INDUCING
AGENT TO BE GIVEN ( pref. ETOMIDATE)
• IF BP FALLS > 20% OF BASELINE THEN USE
INOTROPES INFUSION
• THERE MAY BE HYPERTENSION ALSO, DUE TO
PRE INDUCTION ANXIETY AND SYMPATHETIC
STIMULATION
• MUSCLE RELAXATION AND CONTROLLED
VENTILATION TO ENSURE ADEQUATE
OXYGENATION AND PREVENT HYPERCARBIA
TOTAL INTRAVENOUS ANAESTHESIA
• INFUSION OF PROPOFOL @ 25-100 mcg/kg/min
• REMIFENTANYL 1 mcg/kg FOLLOED BY 0.25-1
mcg/kg INFUSION
• TOATAL DOSE OF FENTANYL SHOULD 5-7 mcg/kg
• REMIFENTANYL should be supplemented by
MORPHINE at the end of sx for post op pain
MIXED INTRAVENOUS ANAESTH.
• MIDAZOLAM 0.05mg/kg FOR SEDATION
• ETOMIDATE 0.1-0.3 mg/kg FOR INDUCTION
• OPIOIDS ARE GIVEN INTERMITTENTLY ( total
dose of fentanyl <15mcg/kg and remifentanyl
< 5mcg/kg)
• IN FRAIL PATIENTS KETAMINE AND
MIDAZOALM PROVIDES HEMODYNAMIC
STABILITY, GOOD AMNESIA,ANALGESIA AND
MINIMAL RESPIRATORY DEPRESSION
INHALATIONAL ANAESTHESIA
• VOLATILE AGENTS 0.5-1.5 MAC for
maintenance of anaesthesia and sympathetic
response suppression
• ISOFLURANE , SEVOFLURANE OR DESFLURANE
CAN BE USED
PRE BYPASS CHECKS
• CHECK B/L AIR ENTRY
• PROTECT EYES
• CHECK ALL MONITORS AND TUBINGS AFTER
FINAL POSITIONING
• ADMINSTER ANTIBIOTICS
• CHECK BASELINE ACT
• CHECK BASELINE ABG
• PRIMING OF BYPASS MACHINE AND CIRCUITS
BY BALANCED SALT SOLUTION (RINGER
LACTATE ETC.) IN SEVERLY ILL PATIENTS WITH
BLOOD
CONSIDERATIONS IN STEPS OF BYPASS
• SKIN INCISION MAY CAUSE SYPATHETIC STIMULATION
SO↑ DEPTH OF ANAESTHESIA SO AMNESIC AGENTS
LIKE BENZODIAZEPINES AND PROPOFOL TO BE USED
• AT THE TIME OF STERNAL SPLITTING THERE MAY BE
PAIN, AWARENESS, TACHYCARDIA AND RAISED BP SO
TO BE MANAGED BY NTG OR ESMOLOL AND
FENTANYL HIGH DOSES
• LUNGS TO BE DEFLATED AT THE TIME OF SPLITTING
BY DISCONNECTION OF GAS FROM WORKSTATION
• HEPARINIZATION BEFORE OPENING PERICARDIUM
ACCORDING TO BASE LINE ACT (target 400-480 secs)
@ 300-400mcg/kg .
CANNULATION IN CPB
• AORTIC CANNULATION IS DONE FIRST TO
ALLOW RAPID VOLUME INFUSION IN CASES
OF HAEMORRHAGE DURING VENOUS
CANNULATION.
• VENOUS CANNULATION OF MAJOR VEINS-SVC
& IVC OR RIGHT ATRIUM.
CARDIOPLULMONARY BYPASS
MACHINE
CPB BASIC CIRCUIT
CARDIOPLEGIA AND HYPOTHERMIA
• THESE ARE TWO IMPORTANT ROUTINELY
USED COMPONENTS OF CPB
• CORE BODY TEMP. IS REDUCED TO 20-32 ◦ ©
PROFOUND HYPOTHERMIA 15-18 ◦© FOR
COMPLEX REPAIR OF AORTA.
• HYPOTHERMIA HELP IN MYOCARDIAL
PRESERVATION AND ↓O2 DEMAND
( metabolic O2 demand generally cut in half with
each 10 degree reduction)
CARDIOPLEGIA
• TO PROVIDE A MOTIONLESS FIELD,HEART IS
STOPPED IN DIASTOLE BY ADMINISTERING A
POTASSIUM RICH CARDIOPLEGIC SOLUTION
• ( it interrupts myocardial electromechanical
activity, reduces O2 consumption by 90% and
cold cardioplegia reduces it by 97% )
• COMPLETE CARDIOPLEGIA ACHIEVED BY BOTH
ANTEGRADE AND RETROGRADE APPROACH
AND IT IS SUPERIOR TO ONLY ANTEGRADE
TECH.
CARDIOPLEGIA
• CARDIOPLEGIA IS USUALLY ADMINISTERED
EVERY 20-30 MINS.(excessive cardioplegia
may cause absence of electrical activity, AV
conduction blockade or a poorly contracting
heart at conclusion of CPB)
• THERE IS OFTEN A PERIOD OF “WASH OUT”
NEEDED IN LONG CASES , TO ALLOW THE
MYOCARDIUM TO CONTRACT FULLY AND
WITHOUT ANY DEPRESSION.
• ARREST IS REVERSED BY REPERFUSING WITH
WARM NORMOKALEMIC BLOOD( HOT SHOT)
INTRA OP MONITORING
• HEMODYNAMIC PARAMETERS –HR/NIBP/
SPO2/ INTRAOP ABGs/ INTRAOP ACT
• IBP-dominant hand radial is prefered
• ECG-to see ST changes and T wave changes
• CVP- internal jugular vein
• PA CATHETER ( SWAN GANZ CATHETER)
• TRANSESOPHAGEAL ECHO- can assess regions
supplied by all three major coronary arteries
and regional wall motion abnormality can be
seen before ECG and PA/SGC changes
MAINTENANCE OF BYPASS
• ACT repeated every 30-60 min, IF LESS –
supplemental Heparin is to be added.
• ABG to be evaluated every 30-60 min.
• PaO2 to be maintained between 100-
300mmHg and PaCO2 between 30-40mmHg.
• Blood Glucose and Haematocrit measured
every 30-60 min.
• DEPTH OF ANAESTHESIA IS MAINTAINED BY
adding anaesthetic agents and muscle
relaxants directly into the circuit and adding
volatile agents by connecting vapourizer to
oxygenator of bypass machine.
• PUMP FLOW RATE is to be maintained
@50-70 ml/kg/min.
• Urine Output to be atleast 0.5ml/kg/hr.
• Core temperature to be monitored at
Nasopharynx or Tympanic membrane.
• DE-AIRING OF HEART TO BE DONE BEFORE
WEANING FROM CPB by increasing venous
pressure by inflating lungs and tapping of
tubings .
WEANING FROM BYPASS
• BEFORE TERMINATION ,PATIENT SHOULD BE
REWARMED ,HEART IS DE-AIRED, REGULAR
CARDIAC ELECTRICAL ACTIVITY CONFIRMED OR
SUPPORTED BY PACE MAKER, LAB VALUES
CONFIRMED AND CORRECTED
• VENTILATION OF LUNGS IS ESTABLISHED BY
CONNECTING TO WORKSTATION WHEN PA
BLOOD FLOW IS RESTORED.
• VENOUS DRAINAGE IS SLOWLY REDUCED AND
CARDIAC FILLING VOLUME IS GRADUALLY
INCREASED.
• VASOPRESSORS OR INOTROPIC SUPPORT MAY BE
NEEDED
•WHEN PT. BECOMES HEMODYNAMICALLY STABLE
PROTAMINE SULPHATE IS ADMINISTERED
1-1.3mg protamine per 100 units of HEPARIN slowly
over 10-15 mins
• ACT should be brought to baseline
•WHEN PRE-LOADING IS OPTIMAL AND
CONTRACTILITY IS ADEQUATE, AORTIC INFLOW LINE
IS CLAMPED TO SEPERATE FROM BYPASS MACHINE.
•VISUALISATION OF HEART BY TEE TO SEE
CONTRACTILITY.
•VOLUME EXPANSION TO BE DONE IF NEEDED.
POST BYPASS
• PATIENT IS SHIFTED TO CARDIAC ICU BEING
INTUBATED AND ON MECHANICAL
VENTILATION FOR 2-12 hrs WITH SEADTION
AND ANALGESIA TO BE CONTINUED
• EXTUBATION IS CONSIDERED WHEN-pt.
become conscious,muscle paralysis gone,ABG
acceptable, surgical hemostasis is adequate
and the patient is hemodynamically stable
BYPASS COMPLICATIONS
• ISCHEMIA AND INFARCTION
• LV DYSFUNCTION
• RV DYSFUNCTION
• RV FAILURE
• HYPOTENSION
• DYSRYTHMIAS (AF MOST COMMON, VF,
BRADYCARDIAS AND HEART BLOCK)
• BLEEDING AND COAGULOPATHY
• ATELECTASIS,HEMOTHORAX/
PNEUMOTHORAX, PULMONARY EDEMA
BYPASS COMPLICATIONS
• METABOLIC DISTURBANCES
(HYPOKALEMIA,HYPERKALEMIA,HYPOCALCEM
IA,HYPOMAGNESEMIA,HYPERGLYCEMIA)
• TRANSIENT NEUROPSYCHIATRIC
DYSFUNCTION AND/OR STROKES
• DECREASED RENAL PERFUSION
OFF PUMP CABG
• OFF PUMP OR BEATING HEART CABG IS SURGERY
WITHOUT CARDIOPULMONARY BYPASS and REQUIRED
IN
1. patients with anterior lesions,single or double vessel disease
2. Pts. With high risk of stroke, renal failure, pulmonary
dysfunction and severe valvular disease.
• Hypothermia is avoided throughout sx.
• Goal of heparin anticoagulation is >2 times of baseline ACT
or >300sec or sometimes >400
• Only focal area of heart is stabilized with epicardial
stablizers.SBPkept< 100mm hg
• HEMODYNAMIC DISTURBANCES AND ARRYTHMIAS ARE
MORE FREQUENT
Cardiopulmonary bypass
Cardiopulmonary bypass

More Related Content

What's hot

Minimally invasive cardiac surgery
Minimally invasive cardiac surgeryMinimally invasive cardiac surgery
Minimally invasive cardiac surgery
Dr Nitin Kumar Rajput
 
WEANING FROM CPB.pptx
WEANING FROM CPB.pptxWEANING FROM CPB.pptx
WEANING FROM CPB.pptx
Manu Jacob
 
Routine cpb weaning
Routine cpb weaningRoutine cpb weaning
Routine cpb weaningAbeer Nakera
 
cardioplegia delivery management, perfusion safety
cardioplegia delivery management, perfusion safetycardioplegia delivery management, perfusion safety
cardioplegia delivery management, perfusion safetyIda Simanjuntak
 
Cardiopulmonary bypass
Cardiopulmonary bypassCardiopulmonary bypass
Cardiopulmonary bypass
Alireza Kashani
 
Ultrafiltration during cardiopulmonary_bypass
Ultrafiltration during cardiopulmonary_bypassUltrafiltration during cardiopulmonary_bypass
Ultrafiltration during cardiopulmonary_bypass
dr amarja nagre
 
Physiology of Cardiopulmonary Bypass
Physiology of Cardiopulmonary BypassPhysiology of Cardiopulmonary Bypass
Physiology of Cardiopulmonary Bypass
kshama_db
 
7 Adequacy Of Perfusion During Cardiopulmonary Bypass
7 Adequacy Of Perfusion During Cardiopulmonary Bypass7 Adequacy Of Perfusion During Cardiopulmonary Bypass
7 Adequacy Of Perfusion During Cardiopulmonary BypassDang Thanh Tuan
 
Cardiopulmonary bypass
Cardiopulmonary bypassCardiopulmonary bypass
Cardiopulmonary bypass
Md Mossabbir Hossain
 
Cardiac output monitoring
Cardiac output monitoringCardiac output monitoring
Cardiac output monitoring
mauryaramgopal
 
CARDIOPULMONARY BYPASS
CARDIOPULMONARY BYPASSCARDIOPULMONARY BYPASS
CARDIOPULMONARY BYPASS
Manu Jacob
 
8.myocardial protection during cpb
8.myocardial protection during cpb8.myocardial protection during cpb
8.myocardial protection during cpb
Manu Jacob
 
Basic principles of myocardial proctection
Basic principles of myocardial proctectionBasic principles of myocardial proctection
Basic principles of myocardial proctection
Raja Lahiri
 
MICS
MICSMICS
cannulation techniques during cpb
cannulation techniques during cpbcannulation techniques during cpb
cannulation techniques during cpb
Manu Jacob
 
Anaesthesia for cardiopulmonary bypass surgery
Anaesthesia for cardiopulmonary bypass surgeryAnaesthesia for cardiopulmonary bypass surgery
Anaesthesia for cardiopulmonary bypass surgery
ZIKRULLAH MALLICK
 
4.hemo filtration &amp; blood conservation technique
4.hemo filtration &amp; blood conservation technique4.hemo filtration &amp; blood conservation technique
4.hemo filtration &amp; blood conservation technique
Manu Jacob
 
Complications and safety during cpb
Complications and safety during cpbComplications and safety during cpb
Complications and safety during cpb
Manu Jacob
 
Cannulation and cardiopulmonary bypass.
Cannulation and cardiopulmonary bypass.Cannulation and cardiopulmonary bypass.
Cannulation and cardiopulmonary bypass.
Manu Jacob
 
Cardiopulmonary bypass razi shahid
Cardiopulmonary bypass razi shahidCardiopulmonary bypass razi shahid
Cardiopulmonary bypass razi shahid
razishahid
 

What's hot (20)

Minimally invasive cardiac surgery
Minimally invasive cardiac surgeryMinimally invasive cardiac surgery
Minimally invasive cardiac surgery
 
WEANING FROM CPB.pptx
WEANING FROM CPB.pptxWEANING FROM CPB.pptx
WEANING FROM CPB.pptx
 
Routine cpb weaning
Routine cpb weaningRoutine cpb weaning
Routine cpb weaning
 
cardioplegia delivery management, perfusion safety
cardioplegia delivery management, perfusion safetycardioplegia delivery management, perfusion safety
cardioplegia delivery management, perfusion safety
 
Cardiopulmonary bypass
Cardiopulmonary bypassCardiopulmonary bypass
Cardiopulmonary bypass
 
Ultrafiltration during cardiopulmonary_bypass
Ultrafiltration during cardiopulmonary_bypassUltrafiltration during cardiopulmonary_bypass
Ultrafiltration during cardiopulmonary_bypass
 
Physiology of Cardiopulmonary Bypass
Physiology of Cardiopulmonary BypassPhysiology of Cardiopulmonary Bypass
Physiology of Cardiopulmonary Bypass
 
7 Adequacy Of Perfusion During Cardiopulmonary Bypass
7 Adequacy Of Perfusion During Cardiopulmonary Bypass7 Adequacy Of Perfusion During Cardiopulmonary Bypass
7 Adequacy Of Perfusion During Cardiopulmonary Bypass
 
Cardiopulmonary bypass
Cardiopulmonary bypassCardiopulmonary bypass
Cardiopulmonary bypass
 
Cardiac output monitoring
Cardiac output monitoringCardiac output monitoring
Cardiac output monitoring
 
CARDIOPULMONARY BYPASS
CARDIOPULMONARY BYPASSCARDIOPULMONARY BYPASS
CARDIOPULMONARY BYPASS
 
8.myocardial protection during cpb
8.myocardial protection during cpb8.myocardial protection during cpb
8.myocardial protection during cpb
 
Basic principles of myocardial proctection
Basic principles of myocardial proctectionBasic principles of myocardial proctection
Basic principles of myocardial proctection
 
MICS
MICSMICS
MICS
 
cannulation techniques during cpb
cannulation techniques during cpbcannulation techniques during cpb
cannulation techniques during cpb
 
Anaesthesia for cardiopulmonary bypass surgery
Anaesthesia for cardiopulmonary bypass surgeryAnaesthesia for cardiopulmonary bypass surgery
Anaesthesia for cardiopulmonary bypass surgery
 
4.hemo filtration &amp; blood conservation technique
4.hemo filtration &amp; blood conservation technique4.hemo filtration &amp; blood conservation technique
4.hemo filtration &amp; blood conservation technique
 
Complications and safety during cpb
Complications and safety during cpbComplications and safety during cpb
Complications and safety during cpb
 
Cannulation and cardiopulmonary bypass.
Cannulation and cardiopulmonary bypass.Cannulation and cardiopulmonary bypass.
Cannulation and cardiopulmonary bypass.
 
Cardiopulmonary bypass razi shahid
Cardiopulmonary bypass razi shahidCardiopulmonary bypass razi shahid
Cardiopulmonary bypass razi shahid
 

Similar to Cardiopulmonary bypass

sagana liver [Autosaved].pptx
sagana liver [Autosaved].pptxsagana liver [Autosaved].pptx
sagana liver [Autosaved].pptx
drsharmila35
 
WEANING FROM CARDIOPULMONARY BYPASS.pptx
WEANING FROM CARDIOPULMONARY BYPASS.pptxWEANING FROM CARDIOPULMONARY BYPASS.pptx
WEANING FROM CARDIOPULMONARY BYPASS.pptx
Mithra Rajasegar
 
TRANSURETHRAL RESECTION OF PROSTATE.pptx
TRANSURETHRAL RESECTION OF PROSTATE.pptxTRANSURETHRAL RESECTION OF PROSTATE.pptx
TRANSURETHRAL RESECTION OF PROSTATE.pptx
Thlamuana Knox
 
ICU management of ECMO pt
ICU management of ECMO ptICU management of ECMO pt
ICU management of ECMO pt
Muhammad Asim Rana
 
Cardiopulmonarybypass
CardiopulmonarybypassCardiopulmonarybypass
Cardiopulmonarybypass
SANDEEP MEWADA
 
Cardiopulmonary Bypass overview for beginners
Cardiopulmonary Bypass overview for beginnersCardiopulmonary Bypass overview for beginners
Cardiopulmonary Bypass overview for beginners
NICS, Bangalore
 
Anaesthesia for off pump coronary artery bypass grafting
Anaesthesia for off pump coronary artery bypass graftingAnaesthesia for off pump coronary artery bypass grafting
Anaesthesia for off pump coronary artery bypass graftingDhritiman Chakrabarti
 
Shock
ShockShock
Shock
Upwork
 
Dr jeevraj cabg management
Dr jeevraj cabg managementDr jeevraj cabg management
Dr jeevraj cabg management
jeevraj24
 
Blocks for upper limb
Blocks for upper limb Blocks for upper limb
Blocks for upper limb
DrKSYasaswi
 
anti arrhythmic drugs anaesthesiology cardiac
anti arrhythmic drugs anaesthesiology  cardiacanti arrhythmic drugs anaesthesiology  cardiac
anti arrhythmic drugs anaesthesiology cardiac
NeelkantRaju
 
Iabp
IabpIabp
Deep hypothermic circulatory arrest in pediatric cardiac sur
Deep hypothermic circulatory arrest in pediatric cardiac surDeep hypothermic circulatory arrest in pediatric cardiac sur
Deep hypothermic circulatory arrest in pediatric cardiac sur
Manu Jacob
 
Anasthesia during cpb
Anasthesia during cpbAnasthesia during cpb
Anasthesia during cpbChandan N
 
TURP.pptx
TURP.pptxTURP.pptx
TURP.pptx
MohamedHasan53
 
ANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptxANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptx
NeelkantRaju
 
TACHYARRHYTHMIAS mechanism powerpoint .pptx
TACHYARRHYTHMIAS  mechanism powerpoint .pptxTACHYARRHYTHMIAS  mechanism powerpoint .pptx
TACHYARRHYTHMIAS mechanism powerpoint .pptx
HemaBalan5
 
Intra aortic balloon pump and ECMO
Intra aortic balloon pump and ECMOIntra aortic balloon pump and ECMO
Intra aortic balloon pump and ECMO
Rachel Jeevakirubai
 
Preparation for separation 2010 final
Preparation for separation 2010 finalPreparation for separation 2010 final
Preparation for separation 2010 finalAbeer Nakera
 

Similar to Cardiopulmonary bypass (20)

sagana liver [Autosaved].pptx
sagana liver [Autosaved].pptxsagana liver [Autosaved].pptx
sagana liver [Autosaved].pptx
 
WEANING FROM CARDIOPULMONARY BYPASS.pptx
WEANING FROM CARDIOPULMONARY BYPASS.pptxWEANING FROM CARDIOPULMONARY BYPASS.pptx
WEANING FROM CARDIOPULMONARY BYPASS.pptx
 
TRANSURETHRAL RESECTION OF PROSTATE.pptx
TRANSURETHRAL RESECTION OF PROSTATE.pptxTRANSURETHRAL RESECTION OF PROSTATE.pptx
TRANSURETHRAL RESECTION OF PROSTATE.pptx
 
ICU management of ECMO pt
ICU management of ECMO ptICU management of ECMO pt
ICU management of ECMO pt
 
Cardiopulmonarybypass
CardiopulmonarybypassCardiopulmonarybypass
Cardiopulmonarybypass
 
Cardiopulmonary Bypass overview for beginners
Cardiopulmonary Bypass overview for beginnersCardiopulmonary Bypass overview for beginners
Cardiopulmonary Bypass overview for beginners
 
Anaesthesia for off pump coronary artery bypass grafting
Anaesthesia for off pump coronary artery bypass graftingAnaesthesia for off pump coronary artery bypass grafting
Anaesthesia for off pump coronary artery bypass grafting
 
Shock
ShockShock
Shock
 
Dr jeevraj cabg management
Dr jeevraj cabg managementDr jeevraj cabg management
Dr jeevraj cabg management
 
Blocks for upper limb
Blocks for upper limb Blocks for upper limb
Blocks for upper limb
 
Genitourinary system
Genitourinary systemGenitourinary system
Genitourinary system
 
anti arrhythmic drugs anaesthesiology cardiac
anti arrhythmic drugs anaesthesiology  cardiacanti arrhythmic drugs anaesthesiology  cardiac
anti arrhythmic drugs anaesthesiology cardiac
 
Iabp
IabpIabp
Iabp
 
Deep hypothermic circulatory arrest in pediatric cardiac sur
Deep hypothermic circulatory arrest in pediatric cardiac surDeep hypothermic circulatory arrest in pediatric cardiac sur
Deep hypothermic circulatory arrest in pediatric cardiac sur
 
Anasthesia during cpb
Anasthesia during cpbAnasthesia during cpb
Anasthesia during cpb
 
TURP.pptx
TURP.pptxTURP.pptx
TURP.pptx
 
ANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptxANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptx
 
TACHYARRHYTHMIAS mechanism powerpoint .pptx
TACHYARRHYTHMIAS  mechanism powerpoint .pptxTACHYARRHYTHMIAS  mechanism powerpoint .pptx
TACHYARRHYTHMIAS mechanism powerpoint .pptx
 
Intra aortic balloon pump and ECMO
Intra aortic balloon pump and ECMOIntra aortic balloon pump and ECMO
Intra aortic balloon pump and ECMO
 
Preparation for separation 2010 final
Preparation for separation 2010 finalPreparation for separation 2010 final
Preparation for separation 2010 final
 

Recently uploaded

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 

Recently uploaded (20)

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 

Cardiopulmonary bypass

  • 1. CARDIOPULMONARY BYPASS DR. ARUN SAGAR JR II MODERATOR: DR RITURAJ
  • 3. CARDIOPULMONARY BYPASS • IT IS TO PROVIDE A NON BEATING BLOODLESS HEART WITH FLOW TEMPORARILY DIVERTED TO AN EXTRA-CORPOREAL CIRCUIT THAT FUNCTIONALLY REPLACES HEART AND LUNGS
  • 4. SURGICAL PROCEDURES REQUIRING CPB • CORONARY ARTERY BYPASS SURGERY • CARDIAC VALVE REPAIR AND/OR REPLACEMENT ( MITRAL VALVE, TRICUSPID VALVE ETC.) • REPAIR OF LARGE SEPTAL DEFECTS ( ASD,VSD ETC.) • REPAIR AND/OR PALLIATION OF CONGENITAL HEART DEFECTS ( TOF , TOGV ETC.) • TRANSPLANTATION ( HEART TRANSPLANT, LUNGS TRANSPLANT ETC. ) • REPAIR OF SOME LARGE ANEURYSMS LIKE AORTIC ANEURYSM • PULMONARY THROMBOENDARTERECTOMY AND THROMBECTOMY
  • 5. PREANAESTHETIC WORKUP • DO THE PAC OF PATIENT WITH HISTORY AND PHYSICAL EXAMINATION,METS ETC. • CBC,COAGULATION PROFILE,RENAL AND LIVER FUNCTION TESTS, • CHEST X RAY, RESTING ECG ,2D ECHO, STRESS ECHO • MYOCARDIAL PERFUSION SCANS • ANGIOGRAPHY • CONTRAST VENTRICULOGRAPHY
  • 6. PATIENT PREPARATION • PUT A 18G OR PREFERABLY 16G CANNULA • AN INTERNAL JUGLAR CENTRAL LINE • A RADIAL AND FEMORAL ARTERIAL LINE( FOR ABG AND IBP ) • PATIENTS BLOOD TAKEN FOR ACT ( ACTIVATED CLOTTING TEST) IT IS TIME FROM ADDING BLOOD TO MACHINE UP TO TIME WHEN FIRST CLOT APPEARS. AN ACT LONGER THAN 400-480 SECS IS CONSIDERED SAFE. • HEPARINIZATION FOR ANTICOAGULATION DURING SURGERY IS BASED ON ACT.
  • 7. PREMEDICATION AND INDUCTION • NARCOTICS OR ANXIOLYTICS OR BOTH FOR PAIN AND ANXIETY AS PREMEDICATION ( PATIENTS WITH EF <40% AND PATIENTS WITH LOW CARDIAC OUTPUT ---SHOULD BE GIVEN PREOP MEDICATIONS SLOWLY AND CAREFULLY TO AVOID MYOCARDIAL DEPRESSION AND HYPOTENSION ) • GOAL OF INDUCTION IS TO AVOID HYPOTENSION AND ATTENUATE HEMODYNAMIC RESPONSE TO LARYNGOSCOPY AND INTUBATION
  • 8. • SMALL INCREMENTAL DOSES OF INDUCING AGENT TO BE GIVEN ( pref. ETOMIDATE) • IF BP FALLS > 20% OF BASELINE THEN USE INOTROPES INFUSION • THERE MAY BE HYPERTENSION ALSO, DUE TO PRE INDUCTION ANXIETY AND SYMPATHETIC STIMULATION • MUSCLE RELAXATION AND CONTROLLED VENTILATION TO ENSURE ADEQUATE OXYGENATION AND PREVENT HYPERCARBIA
  • 9. TOTAL INTRAVENOUS ANAESTHESIA • INFUSION OF PROPOFOL @ 25-100 mcg/kg/min • REMIFENTANYL 1 mcg/kg FOLLOED BY 0.25-1 mcg/kg INFUSION • TOATAL DOSE OF FENTANYL SHOULD 5-7 mcg/kg • REMIFENTANYL should be supplemented by MORPHINE at the end of sx for post op pain
  • 10. MIXED INTRAVENOUS ANAESTH. • MIDAZOLAM 0.05mg/kg FOR SEDATION • ETOMIDATE 0.1-0.3 mg/kg FOR INDUCTION • OPIOIDS ARE GIVEN INTERMITTENTLY ( total dose of fentanyl <15mcg/kg and remifentanyl < 5mcg/kg) • IN FRAIL PATIENTS KETAMINE AND MIDAZOALM PROVIDES HEMODYNAMIC STABILITY, GOOD AMNESIA,ANALGESIA AND MINIMAL RESPIRATORY DEPRESSION
  • 11. INHALATIONAL ANAESTHESIA • VOLATILE AGENTS 0.5-1.5 MAC for maintenance of anaesthesia and sympathetic response suppression • ISOFLURANE , SEVOFLURANE OR DESFLURANE CAN BE USED
  • 12. PRE BYPASS CHECKS • CHECK B/L AIR ENTRY • PROTECT EYES • CHECK ALL MONITORS AND TUBINGS AFTER FINAL POSITIONING • ADMINSTER ANTIBIOTICS • CHECK BASELINE ACT • CHECK BASELINE ABG • PRIMING OF BYPASS MACHINE AND CIRCUITS BY BALANCED SALT SOLUTION (RINGER LACTATE ETC.) IN SEVERLY ILL PATIENTS WITH BLOOD
  • 13. CONSIDERATIONS IN STEPS OF BYPASS • SKIN INCISION MAY CAUSE SYPATHETIC STIMULATION SO↑ DEPTH OF ANAESTHESIA SO AMNESIC AGENTS LIKE BENZODIAZEPINES AND PROPOFOL TO BE USED • AT THE TIME OF STERNAL SPLITTING THERE MAY BE PAIN, AWARENESS, TACHYCARDIA AND RAISED BP SO TO BE MANAGED BY NTG OR ESMOLOL AND FENTANYL HIGH DOSES • LUNGS TO BE DEFLATED AT THE TIME OF SPLITTING BY DISCONNECTION OF GAS FROM WORKSTATION • HEPARINIZATION BEFORE OPENING PERICARDIUM ACCORDING TO BASE LINE ACT (target 400-480 secs) @ 300-400mcg/kg .
  • 15. • AORTIC CANNULATION IS DONE FIRST TO ALLOW RAPID VOLUME INFUSION IN CASES OF HAEMORRHAGE DURING VENOUS CANNULATION. • VENOUS CANNULATION OF MAJOR VEINS-SVC & IVC OR RIGHT ATRIUM.
  • 18.
  • 19.
  • 20.
  • 21. CARDIOPLEGIA AND HYPOTHERMIA • THESE ARE TWO IMPORTANT ROUTINELY USED COMPONENTS OF CPB • CORE BODY TEMP. IS REDUCED TO 20-32 ◦ © PROFOUND HYPOTHERMIA 15-18 ◦© FOR COMPLEX REPAIR OF AORTA. • HYPOTHERMIA HELP IN MYOCARDIAL PRESERVATION AND ↓O2 DEMAND ( metabolic O2 demand generally cut in half with each 10 degree reduction)
  • 22. CARDIOPLEGIA • TO PROVIDE A MOTIONLESS FIELD,HEART IS STOPPED IN DIASTOLE BY ADMINISTERING A POTASSIUM RICH CARDIOPLEGIC SOLUTION • ( it interrupts myocardial electromechanical activity, reduces O2 consumption by 90% and cold cardioplegia reduces it by 97% ) • COMPLETE CARDIOPLEGIA ACHIEVED BY BOTH ANTEGRADE AND RETROGRADE APPROACH AND IT IS SUPERIOR TO ONLY ANTEGRADE TECH.
  • 23. CARDIOPLEGIA • CARDIOPLEGIA IS USUALLY ADMINISTERED EVERY 20-30 MINS.(excessive cardioplegia may cause absence of electrical activity, AV conduction blockade or a poorly contracting heart at conclusion of CPB) • THERE IS OFTEN A PERIOD OF “WASH OUT” NEEDED IN LONG CASES , TO ALLOW THE MYOCARDIUM TO CONTRACT FULLY AND WITHOUT ANY DEPRESSION. • ARREST IS REVERSED BY REPERFUSING WITH WARM NORMOKALEMIC BLOOD( HOT SHOT)
  • 24.
  • 25. INTRA OP MONITORING • HEMODYNAMIC PARAMETERS –HR/NIBP/ SPO2/ INTRAOP ABGs/ INTRAOP ACT • IBP-dominant hand radial is prefered • ECG-to see ST changes and T wave changes • CVP- internal jugular vein • PA CATHETER ( SWAN GANZ CATHETER) • TRANSESOPHAGEAL ECHO- can assess regions supplied by all three major coronary arteries and regional wall motion abnormality can be seen before ECG and PA/SGC changes
  • 26. MAINTENANCE OF BYPASS • ACT repeated every 30-60 min, IF LESS – supplemental Heparin is to be added. • ABG to be evaluated every 30-60 min. • PaO2 to be maintained between 100- 300mmHg and PaCO2 between 30-40mmHg. • Blood Glucose and Haematocrit measured every 30-60 min. • DEPTH OF ANAESTHESIA IS MAINTAINED BY adding anaesthetic agents and muscle relaxants directly into the circuit and adding volatile agents by connecting vapourizer to oxygenator of bypass machine.
  • 27. • PUMP FLOW RATE is to be maintained @50-70 ml/kg/min. • Urine Output to be atleast 0.5ml/kg/hr. • Core temperature to be monitored at Nasopharynx or Tympanic membrane. • DE-AIRING OF HEART TO BE DONE BEFORE WEANING FROM CPB by increasing venous pressure by inflating lungs and tapping of tubings .
  • 28. WEANING FROM BYPASS • BEFORE TERMINATION ,PATIENT SHOULD BE REWARMED ,HEART IS DE-AIRED, REGULAR CARDIAC ELECTRICAL ACTIVITY CONFIRMED OR SUPPORTED BY PACE MAKER, LAB VALUES CONFIRMED AND CORRECTED • VENTILATION OF LUNGS IS ESTABLISHED BY CONNECTING TO WORKSTATION WHEN PA BLOOD FLOW IS RESTORED. • VENOUS DRAINAGE IS SLOWLY REDUCED AND CARDIAC FILLING VOLUME IS GRADUALLY INCREASED. • VASOPRESSORS OR INOTROPIC SUPPORT MAY BE NEEDED
  • 29. •WHEN PT. BECOMES HEMODYNAMICALLY STABLE PROTAMINE SULPHATE IS ADMINISTERED 1-1.3mg protamine per 100 units of HEPARIN slowly over 10-15 mins • ACT should be brought to baseline •WHEN PRE-LOADING IS OPTIMAL AND CONTRACTILITY IS ADEQUATE, AORTIC INFLOW LINE IS CLAMPED TO SEPERATE FROM BYPASS MACHINE. •VISUALISATION OF HEART BY TEE TO SEE CONTRACTILITY. •VOLUME EXPANSION TO BE DONE IF NEEDED.
  • 30. POST BYPASS • PATIENT IS SHIFTED TO CARDIAC ICU BEING INTUBATED AND ON MECHANICAL VENTILATION FOR 2-12 hrs WITH SEADTION AND ANALGESIA TO BE CONTINUED • EXTUBATION IS CONSIDERED WHEN-pt. become conscious,muscle paralysis gone,ABG acceptable, surgical hemostasis is adequate and the patient is hemodynamically stable
  • 31. BYPASS COMPLICATIONS • ISCHEMIA AND INFARCTION • LV DYSFUNCTION • RV DYSFUNCTION • RV FAILURE • HYPOTENSION • DYSRYTHMIAS (AF MOST COMMON, VF, BRADYCARDIAS AND HEART BLOCK) • BLEEDING AND COAGULOPATHY • ATELECTASIS,HEMOTHORAX/ PNEUMOTHORAX, PULMONARY EDEMA
  • 32. BYPASS COMPLICATIONS • METABOLIC DISTURBANCES (HYPOKALEMIA,HYPERKALEMIA,HYPOCALCEM IA,HYPOMAGNESEMIA,HYPERGLYCEMIA) • TRANSIENT NEUROPSYCHIATRIC DYSFUNCTION AND/OR STROKES • DECREASED RENAL PERFUSION
  • 33. OFF PUMP CABG • OFF PUMP OR BEATING HEART CABG IS SURGERY WITHOUT CARDIOPULMONARY BYPASS and REQUIRED IN 1. patients with anterior lesions,single or double vessel disease 2. Pts. With high risk of stroke, renal failure, pulmonary dysfunction and severe valvular disease. • Hypothermia is avoided throughout sx. • Goal of heparin anticoagulation is >2 times of baseline ACT or >300sec or sometimes >400 • Only focal area of heart is stabilized with epicardial stablizers.SBPkept< 100mm hg • HEMODYNAMIC DISTURBANCES AND ARRYTHMIAS ARE MORE FREQUENT